G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2011
12/15/2011	US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
12/15/2011	US20110305715 Antibodies to 3-hydroxycotinine and methods of use thereof
12/15/2011	US20110305707 Compositions and methods for treating cancer
12/15/2011	US20110305705 Antibodies to thymic stromal lymphopoietin receptor molecules and uses thereof
12/15/2011	US20110305704 Antibody to cytolethal distending toxin of campylobacter jejuni
12/15/2011	US20110305703 Isolated vegf-c and vegf-d peptides and uses thereof
12/15/2011	US20110305695 Wnt Antagonists and Methods of Treatment and Screening
12/15/2011	US20110305691 Modified polypeptides stabilized in a desired conformation and methods for producing same
12/15/2011	US20110305639 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
12/15/2011	US20110305634 Methods and systems for adenovirus interaction with desmoglein 2 (DSG2)
12/15/2011	US20110305633 Methods for Treatment, the Prognostic Assessment and the Detection of Breast Cancer
12/15/2011	US20110305630 Misfolded proteins in cancer treatment and diagnosis
12/15/2011	US20110305600 Microchip solution sending system
12/15/2011	US20110305599 Optical sensor of bio-molecules using thin-film interferometer
12/15/2011	US20110305598 Microfluidic device
12/15/2011	US20110303556 Device and method for measuring prothrombin time and hematocrit by analyzing change in reactance in a sample
12/15/2011	US20110302992 Apparatus for measurement of gas concentrations in breath
12/15/2011	DE19823719B4 Verfahren zum Aufkonzentrieren von Substanzen A method for the concentration of substances
12/15/2011	DE102010029853A1 Sample recording arrangement for facilitating antiseptic handling of fluid sample in e.g. Life Science apparatus, for carrying out e.g. electrophoresis separation, has sample container released by operations of recording structure
12/15/2011	DE102010005622A1 Film test for transporting adhesive films for the microscopic investigation of the surfaces, comprises films, which are characterized by optimization for the investigation of the microorganisms on the surfaces
12/15/2011	DE102009015188B4 Anlage zur Entnahme von Abgasproben von Verbrennungskraftmaschinen und deren Verwendung Plant for the removal of exhaust sample of internal combustion engines and their use
12/15/2011	DE102005011579B4 Affinitätsmarker zur Proteinreinigung, seine Herstellung und Verwendung sowie Verfahren zur Aufreinigung eines Proteins Affinity tag for protein purification, its preparation and use as well as methods for the purification of a protein
12/15/2011	DE10152404B4 Laser-Mikrodissektionssystem Laser microdissection
12/15/2011	DE10126054B4 Analysegerät Analyzer
12/15/2011	CA2814155A1 Anti-tim-3 antibody
12/15/2011	CA2805465A1 Diagnosis of myocardial autoimmunity in heart disease
12/15/2011	CA2802059A1 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding
12/15/2011	CA2802049A1 Scanning multifunctional particles
12/15/2011	CA2801954A1 Wellbore screen with tracer for fluid detection
12/15/2011	CA2801952A1 Wellbore fluid treatment tubular and method
12/15/2011	CA2801894A1 Filtration methods and devices
12/15/2011	CA2801863A1 Method, array and use thereof
12/15/2011	CA2801853A1 Device and method intended to measure the properties of a complex medium by analysis of the variation in backscattered and/or transmitted light
12/15/2011	CA2801630A1 Method and apparatus for determining the local spatial extent of the phase of valuable mineral in a rock
12/15/2011	CA2801107A1 Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
12/15/2011	CA2800938A1 A method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood
12/15/2011	CA2798938A1 Slope-based compensation including secondary output signals
12/15/2011	CA2798031A1 Underfill management system for a biosensor
12/15/2011	CA2791627A1 Mass spectrometric measurement of .beta.-lactamase resistances
12/14/2011	EP2395359A2 Systems and Methods for Performing Measurements of One or More Materials
12/14/2011	EP2395358A2 Covalent tethering of functional groups to proteins and substrates therefor
12/14/2011	EP2395357A1 Method for analyzing psa, and method for distinguishing between prostate cancer and prostatomegaly employing the analysis method
12/14/2011	EP2395356A1 Microchip solution sending system
12/14/2011	EP2395355A1 Homogenous activity test for determining enzymatic reactions
12/14/2011	EP2395354A1 Homogenous activity test for determining enzymatic reactions
12/14/2011	EP2395353A1 Device and method for measuring prothrombin time and hematocrit by analyzing change in reactance in a sample
12/14/2011	EP2395352A1 Method and device for determining the local extension of mineral material in a rock
12/14/2011	EP2395347A1 Device and method for performing electrical impedance tomography
12/14/2011	EP2395110A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395109A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395108A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395107A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395106A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395105A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395104A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395103A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395102A1 Method for measuring resistance or sensitivity to docetaxel
12/14/2011	EP2395100A2 Novel diagnostic marker for type 1 diabetes mellitus
12/14/2011	EP2395020A2 IL-18 binding proteins
12/14/2011	EP2394944A1 Thread-fluff-dust sensor assembly
12/14/2011	EP2394662A2 Methods and compositions for treating and preventing disease associated with AlphavBeta5 intergrin
12/14/2011	EP2394660A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
12/14/2011	EP2394659A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
12/14/2011	EP2394655A2 Epitope sequences
12/14/2011	EP2394577A2 Diagnostic meter
12/14/2011	EP2394289A1 Method of mass spectrometry
12/14/2011	EP2394174A2 Biomarkers of hemorrhagic shock
12/14/2011	EP2394173A2 Immunoglobulin glycosylation pattern analysis
12/14/2011	EP2394172A1 Method of prognosis and/or diagnosing an irs in a patient infected with m. tuberculosis, and optionally hiv
12/14/2011	EP2394171A2 Autosomal dominant polycystic kidney disease (adpkd)
12/14/2011	EP2394170A2 Methods of detecting colorectal cancer
12/14/2011	EP2394169A1 Encapsulated nanoparticles
12/14/2011	EP2394168A1 Method and apparatus for testing transdermal medicaments
12/14/2011	EP2394167A1 Surface-deposited particle and substance sampling, dilution and analysis device
12/14/2011	EP2394166A1 Methods and compositions for diagnosis and prognosis of renal injury and failure
12/14/2011	EP2394165A1 Oligomer sequences mapping
12/14/2011	EP2394164A2 Oligomer sequences mapping
12/14/2011	EP2394163A1 Methods for the detection of jc polyoma virus
12/14/2011	EP2394162A2 Measurement of textile fabrics
12/14/2011	EP2394161A2 Method and apparatus for measuring fluorescence in liquids
12/14/2011	EP2394160A1 Method of detecting contamination of water using living organisms
12/14/2011	EP2394159A2 Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
12/14/2011	EP2393946A1 Determination of the liver toxicity of an agent
12/14/2011	EP2393938A1 Cell based assays for the triglyceride synthesis pathway
12/14/2011	EP2393937A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
12/14/2011	EP2393936A2 Compositions, kits, and methods for determining plasmin activity
12/14/2011	EP2393934A1 Diagnosis and prognosis of renal injury and renal failure
12/14/2011	EP2393930A2 Cell lines expressing cftr and methods of using them
12/14/2011	EP2393824A2 Plasmodium malariae and plasmodium ovale genes and uses thereof
12/14/2011	EP2393520A1 Structured peptide processing
12/14/2011	EP2393519A1 Multispecific peptides
12/14/2011	EP2393518A1 Structured polycyclic peptide
12/14/2011	EP2393498A1 Cancer diagnosis and treatment
12/14/2011	EP2247932B1 Helium sensor
12/14/2011	EP2171472B1 In vitro method for the determination of glycemic index of food products
12/14/2011	EP2158213B1 Vm23 and vm24, two scorpion peptides that block human t-lymphocyte potassium channels (sub-type kv1.3) with high selectivity
12/14/2011	EP2032989B1 Igfbp2 biomarker
12/14/2011	EP2005162B1 Screening method
12/14/2011	EP1986543B1 Analyte sensor
12/14/2011	EP1943272B1 Novel cxc-chemokine antagonists

1 ... 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 ... 3937